278 related articles for article (PubMed ID: 2250107)
21. Neonatal lupus erythematosus: HLA-DR and -DQ distributions are different among the groups of anti-Ro/SSA-positive mothers with different neonatal outcomes.
Miyagawa S; Shinohara K; Kidoguchi K; Fujita T; Fukumoto T; Yamashina Y; Hashimoto K; Yoshioka A; Sakurai S; Nishihara O; Shirai T
J Invest Dermatol; 1997 Jun; 108(6):881-5. PubMed ID: 9182815
[TBL] [Abstract][Full Text] [Related]
22. A characteristic cutaneous direct immunofluorescent pattern associated with Ro(SS-A) antibodies in subacute cutaneous lupus erythematosus.
Valeski JE; Kumar V; Forman AB; Beutner EH; Chorzelski TP
J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):194-8. PubMed ID: 1430355
[TBL] [Abstract][Full Text] [Related]
23. ANA negative systemic lupus erythematosus sera revisited serologically.
Reichlin M
Lupus; 2000; 9(2):116-9. PubMed ID: 10787008
[TBL] [Abstract][Full Text] [Related]
24. Neonatal lupus syndrome associated with ribonucleoprotein antibodies.
Heelan K; Watson R; Collins SM
Pediatr Dermatol; 2013; 30(4):416-23. PubMed ID: 23432184
[TBL] [Abstract][Full Text] [Related]
25. Neonatal lupus erythematosus: maternal IgG antibodies bind to a recombinant NH2-terminal fusion protein encoded by human alpha-fodrin cDNA.
Miyagawa S; Yanagi K; Yoshioka A; Kidoguchi K; Shirai T; Hayashi Y
J Invest Dermatol; 1998 Dec; 111(6):1189-92. PubMed ID: 9856838
[TBL] [Abstract][Full Text] [Related]
26. The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus.
Magro CM; Crowson AN
Am J Dermatopathol; 1999 Apr; 21(2):129-37. PubMed ID: 10218672
[TBL] [Abstract][Full Text] [Related]
27. IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus.
Bijl M; Dijstelbloem HM; Oost WW; Bootsma H; Derksen RH; Aten J; Limburg PC; Kallenberg CG
Rheumatology (Oxford); 2002 Jan; 41(1):62-7. PubMed ID: 11792881
[TBL] [Abstract][Full Text] [Related]
28. Chilblain lupus erythematosus is associated with antibodies to SSA/Ro.
Franceschini F; Calzavara-Pinton P; Quinzanini M; Cavazzana I; Bettoni L; Zane C; Facchetti F; Airò P; McCauliffe DP; Cattaneo R
Lupus; 1999; 8(3):215-9. PubMed ID: 10342714
[TBL] [Abstract][Full Text] [Related]
29. Ro/SSA antigen in human epidermis.
Jones SK; Coulter S; Harmon C; Norris DA; Rosandich M; Lee LA
Br J Dermatol; 1988 Mar; 118(3):363-7. PubMed ID: 3258526
[TBL] [Abstract][Full Text] [Related]
30. [Neonatal lupus erythematosus: analysis of 8 cases].
Yang Q; Shao XM; Cao Y; Chen C; Cheng GQ; Shi YY; Zhou LJ
Zhonghua Er Ke Za Zhi; 2008 Jan; 46(1):18-21. PubMed ID: 18353232
[TBL] [Abstract][Full Text] [Related]
31. Counterimmunoelectrophoresis, ELISA and immunoblotting detection of anti-Ro/SSA antibodies in subacute cutaneous lupus erythematosus. A comparative study.
Parodi A; Drosera M; Barbieri L; Rebora A
Br J Dermatol; 1998 Jan; 138(1):114-7. PubMed ID: 9536232
[TBL] [Abstract][Full Text] [Related]
32. Maternal autoantibodies and pregnancy--II: The neonatal lupus syndrome.
Lee LA
Baillieres Clin Rheumatol; 1990 Apr; 4(1):69-84. PubMed ID: 2282663
[TBL] [Abstract][Full Text] [Related]
33. Non-cardiac manifestations of neonatal lupus erythematosus.
Silverman E; Jaeggi E
Scand J Immunol; 2010 Sep; 72(3):223-5. PubMed ID: 20696019
[TBL] [Abstract][Full Text] [Related]
34. Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts.
Garcia S; Nascimento JH; Bonfa E; Levy R; Oliveira SF; Tavares AV; de Carvalho AC
J Clin Invest; 1994 Feb; 93(2):718-24. PubMed ID: 8113406
[TBL] [Abstract][Full Text] [Related]
35. IgG subclass and light chain distribution of anticardiolipin and anti-DNA antibodies in systemic lupus erythematosus.
Gharavi AE; Harris EN; Lockshin MD; Hughes GR; Elkon KB
Ann Rheum Dis; 1988 Apr; 47(4):286-90. PubMed ID: 3129997
[TBL] [Abstract][Full Text] [Related]
36. Neonatal lupus erythematosus: a 20-year retrospective study.
Singalavanija S; Limpongsanurak W; Aoongern S
J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S74-82. PubMed ID: 25391176
[TBL] [Abstract][Full Text] [Related]
37. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
38. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
Popovic K; Nyberg F; Wahren-Herlenius M; Nyberg F
Arthritis Rheum; 2007 Jan; 56(1):255-64. PubMed ID: 17195229
[TBL] [Abstract][Full Text] [Related]
39. A monoclonal Ro-antibody and the serum of a Ro-positive patient with subacute cutaneous lupus erythematosus (SCLE) react with basal layers of human epidermis.
Mayet WJ; Bachmann M; Pfeifer K; Schröder HC; Müller WE; Gudat W; Korting GW; Meyer zum Büschenfelde KH
Eur J Clin Invest; 1988 Oct; 18(5):465-71. PubMed ID: 3147897
[TBL] [Abstract][Full Text] [Related]
40. Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus.
Zeng Y; Zhang Y; Chen Q; Huang Q; Lin Y; Wang X; Wang JJ; Jiang L; Xiao Y
Lupus; 2021 May; 30(6):901-912. PubMed ID: 33622075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
